Acute Respiratory Distress Syndrome (ARDS) Clinical Trials

Find Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Near You

Effect of EIT-guided PEEP On Clinical Outcomes in ARDS Patients: a Multicenter Randomized Controlled Trial

Status: Recruiting
Location: See all (17) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Acute respiratory syndrome distress (ARDS) is a clinical common syndrome with high mortality. Mechanical ventilation (MV) is the cornerstone of management of ARDS but can lead to ventilator-induced lung injury. Positive end-expiratory pressure (PEEP), as one of main component of MV, has been widely used in the clinical practice. However, the PEEP selection is still a difficult problem for moderate to severe ARDS patients. EIT, an imaging tool evaluating the regional ventilation distribution at the bedside, can achieve the individual PEEP selection for all mechanically ventilated patients. Our previous study found that moderate to severe ARDS patients with higher recruitability could benefit from EIT-guided PEEP. This article compared the effect of PEEP titrated guided by EIT with fraction of inspired oxygen (FiO2)-PEEP table on the clinical outcomes in ARDS patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Maximum Age: 90
Healthy Volunteers: f
View:

• Age≥18 years

• Moderate-to-severe ARDS, defined by the ARDS Definition Task Force in the Berlin definition (partial pressure of arterial oxygen \[PaO2\]:FiO2 ratio ≤200 mmHg with a PEEP ≥5 cmH2O)

• Diagnosis of ARDS less than 72 hours

Locations
Other Locations
China
Affiliated Beijing Chaoyang Hospital of Capital Medical University
NOT_YET_RECRUITING
Beijing
The First Affiliated Hospital of Guangzhou Medical University
NOT_YET_RECRUITING
Guangzhou
Run Run Shaw Hospital affiliated to Zhejiang University School of Medicine
NOT_YET_RECRUITING
Hangzhou
The Affiliated Hospital of Hangzhou Normal University
NOT_YET_RECRUITING
Hangzhou
Second Hospital of Anhui Medical University
NOT_YET_RECRUITING
Hefei
The First Affiliated Hospital of Nanchang University
NOT_YET_RECRUITING
Nanchang
Zhongda Hospital, School of Medicine, Southeast University
RECRUITING
Nanjing
People's Hospital of Quzhou
NOT_YET_RECRUITING
Quzhou
Department of Critical Care Medicine, Renji Hospital
NOT_YET_RECRUITING
Shanghai
Department of Critical Care Medicine, Zhongshan Hospital of Fudan University
RECRUITING
Shanghai
Ruijin Hospital Shanghai Jiaotong University School Of Medicine
NOT_YET_RECRUITING
Shanghai
First Affiliated Hospital of Xi'an Jiaotong University
NOT_YET_RECRUITING
Xian
Qinghai University Affiliated Hospital
NOT_YET_RECRUITING
Xining
The Affiliated Hospital of Xuzhou Medical University
NOT_YET_RECRUITING
Xuzhou
Zhengzhou Central Hospital Affiliated to Zhengzhou University
NOT_YET_RECRUITING
Zhengzhou
Republic of Korea
Asan Medical Center
NOT_YET_RECRUITING
Seoul
Taiwan
Taichung Veterans General Hospital
NOT_YET_RECRUITING
Taichung
Contact Information
Primary
yuan xue yan, MD, MD
18826401594@163.com
+86 83262550
Time Frame
Start Date: 2026-03-13
Estimated Completion Date: 2030-02-20
Participants
Target number of participants: 2400
Treatments
Experimental: EIT-guided PEEP group
Patients will receive PEEP titrated by EIT with a stepwise decrease PEEP trial
No_intervention: low PEEP-FiO2 table group
PEEP will be set according to the low FiO2-PEEP table to keep the oxygenation goals: SpO2 between 90% and 96%, and PaO2 between 60mmHg and 90mmHg.
Sponsors
Leads: Southeast University, China

This content was sourced from clinicaltrials.gov